Paper Microfluidic Chip for Cystatin-C Measurement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring cystatin-C, a superior biomarker for kidney function, are complex, expensive, and require laboratory facilities, limiting their availability for diagnosing chronic kidney disease, especially in resource-limited settings.
Innovation Solution
A paper-based microfluidic device with optimized flow channels and detection points, utilizing capillary flow and gold nanoparticle-labeled antibodies, allows for low-cost, portable, and accurate measurement of cystatin-C in a drop of blood, compatible with point-of-care diagnostics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional ELISA assays and radioimmunoassay are used for cystatin-C measurement, then measurement accuracy is improved, but device complexity and facility requirements increase
Solution Approach 1:
The patent employs disposable paper-based microfluidic chips with pre-loaded reagents and antibodies. Each chip is a single-use device that integrates the entire assay system, eliminating the need for complex reusable equipment. The paper substrate serves as a disposable platform that guides fluid flow and contains reaction zones, providing accurate cystatin-C measurement without requiring expensive laboratory equipment.
Solution Approach 2:
The paper-based microfluidic device performs self-service through capillary-driven fluid flow that automatically transports samples and reagents through the assay channels without external pumping. The paper matrix itself provides the driving force for fluid movement and reaction mixing, eliminating the need for complex mechanical fluid handling systems while maintaining measurement accuracy.
2Measurement precision
If traditional ELISA assays are used for cystatin-C measurement, then measurement accuracy is improved, but reagent consumption increases
Solution Approach 1:
The patent extracts only the essential measurement function from traditional ELISA assays by implementing a simplified lateral flow format on paper. This extraction removes unnecessary reagent steps and volumes while preserving the core antigen-antibody reaction mechanism. The device uses minimal reagent volumes confined to specific zones on the paper substrate, achieving accurate cystatin-C measurement with significantly reduced reagent consumption.
Solution Approach 2:
The paper-based device applies reagents locally at specific zones rather than requiring uniform reagent distribution throughout large well plates. Antibodies and other reagents are positioned at precise locations on the paper substrate where they interact with the sample in confined reaction zones, reducing overall reagent volume while maintaining measurement accuracy through localized high-concentration interactions.
3Measurement precision
If cystatin-C measurement is performed using conventional methods, then diagnostic accuracy is improved, but cost increases
Solution Approach 1:
The patent utilizes inexpensive paper substrates as the foundation for the measurement device. Paper is a low-cost, readily available material that can be manufactured at scale. The disposable nature of the paper-based chip eliminates the need for expensive instrumentation, making high-accuracy cystatin-C measurement accessible in resource-limited settings while maintaining diagnostic accuracy through optimized assay design.
Solution Approach 2:
The paper-based microfluidic device creates a simplified copy of the traditional ELISA assay functionality using low-cost materials. Instead of replicating the complex mechanical and electronic systems of laboratory equipment, the invention copies the essential chemical reactions and fluid handling functions using paper's inherent properties, achieving diagnostic accuracy at a fraction of the manufacturing cost.
4Measurement precision
If laboratory-based cystatin-C measurement is used, then measurement accuracy is improved, but portability decreases
Solution Approach 1:
The patent employs a thin paper-based substrate that serves as the complete measurement platform. This flexible, lightweight film structure replaces bulky laboratory equipment while maintaining assay functionality. The paper substrate can be easily transported to remote locations and used at the point of care, providing accurate cystatin-C measurement without the portability constraints of traditional laboratory-based methods.
Solution Approach 2:
The device performs self-service through passive capillary flow that requires no external power source or mechanical intervention. The paper matrix automatically drives fluid flow and reaction processes, eliminating the need for portable batteries, pumps, or electronic controls that would compromise simplicity. This self-service mechanism enables accurate cystatin-C measurement in remote settings while maintaining portability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device provides stable, quantitative, and cost-effective cystatin-C measurement, enabling reliable diagnosis and monitoring of chronic kidney disease with minimal equipment and training, suitable for resource-limited settings.
Implementation Method 1
a paper-based substrate, and on a surface of the paper-based substrate: a conjugate pad well; a first flow channel having a first end and a distal second end and comprising a first detection point and a first control point
Data Source
AI summary
Provided are paper-based microfluidic devices for measurement of cystatin C in a biological sample, such as blood or a blood fraction, and methods for fabricating such devices. Also provided are methods of detecting cystatin C in a biological fluid sample to diagnose or monitor a chronic kidney disease.